Trichy Daily

Parkinson’s disease Market: Industry Analysis, Pipeline Therapies, Companies and Forecast by DelveInsight | Impax Laboratories, Luye Pharma, AbbVie, Living Cell Technologies, Novartis

 Breaking News
  • No posts were found

Parkinson’s disease Market: Industry Analysis, Pipeline Therapies, Companies and Forecast by DelveInsight | Impax Laboratories, Luye Pharma, AbbVie, Living Cell Technologies, Novartis

April 17
07:02 2021
Parkinson's disease Market: Industry Analysis, Pipeline Therapies, Companies and Forecast by DelveInsight | Impax Laboratories, Luye Pharma, AbbVie, Living Cell Technologies, Novartis

Parkinson’s disease Market

 

DelveInsight’s “Parkinson’s Disease Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Parkinson’s Disease, historical and forecasted epidemiology as well as the Parkinson’s Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Parkinson’s Disease market size was USD 1837.90 million in 2017 in the 7MM.  Among the 7 Major Markets, the United States accounted for the majority of the market size, with USD 941.13 million followed by Germany, which has the second-highest market size after the United States in 2017.

 

Some of the facts of the report

  • Parkinson’s Disease total prevalent population in the 7MM countries was observed to be 1,608,367 in 2017 and is growing at a CAGR of 0.54% for the study period [2017–2028].
  • Parkinson’s Disease total diagnosed prevalent population was 1,373,639 in 2017.
  • Parkinson’s Disease diagnosed prevalent population was assessed to be the highest for the United States that accounts for 44.29% of the total patient pool among the 7MM countries.

 

Request for Free sample Report: https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

 

Key benefits of the report

1. Parkinson’s Disease market report covers a detailed overview and comprehensive insight of the Parkinson’s Disease Epidemiology and Parkinson’s Disease market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. Parkinson’s Disease market report provides insights into the current and emerging Parkinson’s Disease therapies.

3. Parkinson’s Disease market report offers a global historical and forecasted market covering drug outreach in 7MM.

4. Parkinson’s Disease market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Parkinson’s Disease market.

The age-specific prevalence data showed that the majority of the cases were diagnosed in the age-group of 65-84 years, followed by those aged 45-64 years in the 7MM countries.

 

The key Parkinson’s Disease market players have the potential to create a significant positive shift in Parkinson’s Disease Market Size. Some of the companies involved are:-

1.    US WorldMeds LLC

2.    Intec Pharma

3.    Sunovion Pharma

4.    Pharma Two B Ltd.

5.    Impax Laboratories

6.    Luye Pharma

7.    AbbVie

8.    Living Cell Technologies

9.    Novartis

10.   Neurocrine Biosciences

And many others

 

Get a free sample page : https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

 

There are currently no disease‐modifying drugs, but Parkinson’s Disease treatments are used to offer major symptomatic relief of the motor symptoms. They offer little benefit clinically in terms of the nonmotor manifestations. The present Parkinson’s Disease treatment options include surgery, medication, complementary and supportive therapies (such as diet, exercise, physical therapy, occupational therapy, and speech therapy). The approved medication therapies are categorized into seven groups that include Levodopa, Carbidopa‐levodopa infusion (Duodopa), Dopamine agonists, MAO B inhibitors, Catechol O‐methyltransferase (COMT) inhibitors, Anticholinergics and Amantadine. The drug to be used at the beginning of Parkinson’s Disease treatment is either levodopa or a dopamine agonist. L‐Dopa, a natural precursor of dopamine that is transformed in the brain into dopamine.

Besides gene therapy, stem cell therapy have also shown a more effective Parkinson’s Disease treatment option. Stem cell research in Parkinson’s Disease is focusing on understanding nerve cells development and how healthy cells can be used to replace unhealthy brain cells. 

 

The expected launch of emerging therapies is believed to create a positive impact on Parkinson’s Disease market size in the upcoming years.

1.    Apomorphine Infusion

2.    Accordion Pill Carbidopa/Levodopa

3.    APL–130277

4.    P2B001

5.    IPX203

6.    LY03003

7.    ABBV‐951

8.    NTCELL Implantation

9.    Nilotinib

10.    VY‐AADC

And many others

 

Request for Free sample Report: https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

 

 

Table of Contents 

1

Parkinson’s Disease Key Insights

2

Executive Summary of Parkinson’s Disease  

3

Parkinson’s Disease Market Overview at a Glance

4

Parkinson’s Disease Case Reports 

5

Parkinson’s Disease Epidemiology and Patient Population

6

Country Wise-Epidemiology of Parkinson’s Disease

6.1

The United States Epidemiology

6.2

EU5 Countries Epidemiology

6.2.1

Germany

6.2.2

France

6.2.3

Italy

6.2.4

Spain

6.2.5

The United Kingdom

6.3

Japan Epidemiology

7

Treatment and Management of Parkinson’s Disease

8

Parkinson’s Disease Unmet Needs

9

Parkinson’s Disease Marketed Drugs

9.1

Istradefylline (KW-6002): Kyowa Kirin

9.2

Opicapone: BIAL

9.3

Gocovri: Adamas Pharmaceuticals

9.4

Xadago: Zambon SpA

9.5

Osmolex ER: Osmotica Pharmaceutical

9.6

Duopa (Duodopa, ABT-SLV187): AbbVie

9.7

Rytary: Impax Laboratories (Amneal Pharmaceuticals)

9.8

Inbrija: Acorda Therapeutics

9.9

Nuplazid: ACADIA Pharmaceuticals Inc.

10

Parkinson’s Disease Emerging Drugs

10.1

Apomorphine Infusion: US WorldMeds LLC

10.2

Accordion Pill Carbidopa/Levodopa: Intec Pharma

10.3

P2B001: Pharma Two B Ltd.

10.4

IPX203: Impax Laboratories (Amneal Pharmaceuticals)

10.5

LY03003: Luye Pharma

10.6

ABBV-951: AbbVie

10.7

Allo iPS cell-derived dopamine neural progenitor: Sumitomo Dainippon Pharma

10.8

Solriamfetol (JZP-110): Jazz Pharmaceuticals

10.9

NBIb-1817 (VY-AADC): Neurocrine Biosciences/Voyager Therapeutics

10.10

AAV-GAD: MeiraGTx Limited

10.11

AXO-Lenti-PD (OXB-102): Axovant Sciences

10.12

ND0612: NeuroDerm

10.13

ITI-214: Intracellular Therapies

10.14

IRL752: Integrative Research Laboratories AB (IRLAB)

10.15

PR001: Prevail Therapeutics

10.16

ISC-hpNSC: International Stem Cell Corporation

11

7MM Parkinson’s Disease Market Analysis

11.1

The United States Parkinson’s Disease Market Size

11.2

EU-5 Parkinson’s Disease Market Size

11.2.1

Germany Market Size

11.2.2

France Market Size

11.2.3

Italy Market Size

11.2.4

Spain Market Size

11.2.5

The United Kingdom Market Size

11.3

Japan Parkinson’s Disease Market Size

12

Parkinson’s Disease Market Drivers

13

Parkinson’s Disease Market Barriers

14

SWOT Analysis of Parkinson’s Disease

15

KOL Views

16

Parkinson’s Disease Market Access and Reimbursement

17

Appendix

18

DelveInsight Capabilities

19

Disclaimer

20

About DelveInsight

 

Request for Deatiled TOC: https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment

Related Articles